Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

YouTube Chief Talks About Handling Misinformation

Alphabet Inc’s (NASDAQ:GOOG) (NASDAQ:GOOGL) YouTube can continuously improve its work to combat misinformation, CEO Susan Wojcicki said, Bloomberg reports. “Running a company that has that really focused on free speech, we want to make sure that we’re enabling a broad set of opinions that everyone has a right to express their point…

Benzinga

What Does The Recent String Of Tesla Price Target Cuts Suggest?

As Tesla, Inc. (NASDAQ: TSLA) stock tumbled to a 10-month low, bullish sell-side analysts who had rallied behind the company and saw it as one waiting to explode began to backtrack.

Benzinga

Lyft Pauses Hiring, Budgets To Beat Slowdown Following Uber's Footsteps

Lyft, Inc (NASDAQ:LYFT) looks to slow hiring, reducing some of its departments' budgets and granting new stock options to some employees to make up for its share price fall, the Wall Street Journal reports. Lyft joined rival Uber Technologies, Inc (NYSE:UBER) in outlining cuts as investor optimism cooled on tech stocks. Lyft looked to prioritize fewer…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Short Volatility Alert: IntriCon Corporation

On Tuesday, shares of IntriCon Corporation (NASDAQ: IIN) experienced volatile short activity. After the activity, the stock price went up 0.4% to $24.24 The overall sentiment for IIN has been Bullish.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.

Benzinga

Citius Pharma To Spinoff Late-Stage Oncology Asset Into New Publicly Traded Firm

Citius Pharmaceuticals Inc (NASDAQ:CTXR) plans to form a new company (NewCo) focused on developing and commercializing I/ONTAK. A Phase 3 trial was completed in December 2021, and a biologics license application (BLA) is being planned for submission in the second half of 2022. The Company's other pipeline assets, including Mino-Lok, would remain at…

Benzinga

Starbucks Stock Brews A Setup For Bulls, Bears: Here's Where To Watch For The Break

Starbucks Corporation (NASDAQ: SBUX) was trading mostly flat Wednesday morning, following a number of days when the stock has traded in a tight $5 range between $68.39 and $73.47 in consolidation.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

PC Connection Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, PC Connection (NASDAQ:CNXN) earned $21.79 million, a 2.65% increase from the preceding quarter. PC Connection's sales decreased to $788.34 million, a 1.48% change since Q4.

Benzinga

Hain Celestial Group's Return On Capital Employed Insights

According to Benzinga Pro data Hain Celestial Group (NASDAQ:HAIN) posted a 20.58% decrease in earnings from Q2. Sales, however, increased by 5.45% over the previous quarter to $502.94 million.

Benzinga

Gogo's Return on Invested Capital Overview

According to Benzinga Pro data Gogo (NASDAQ:GOGO) posted a 89.85% decrease in earnings from Q4. Sales, however, increased by 0.49% over the previous quarter to $92.75 million.

Benzinga

Fortune 500 List Includes Cryptocurrency Company For The First Time; 30 Return After Missing 2021

Fortune released its annual Fortune 500 list, ranking the largest companies in America by revenue. The list included a cryptocurrency company for the first time and saw several newcomers from the previous year.

Benzinga

Looking Into Papa John's International's Return On Invested Capital

According to Benzinga Pro data Papa John's International (NASDAQ:PZZA) posted a 55.26% decrease in earnings from Q4. Sales, however, increased by 2.61% over the previous quarter to $542.69 million.

Benzinga

ACI Worldwide's Return on Invested Capital Insights

Pulled from Benzinga Pro data, ACI Worldwide (NASDAQ:ACIW) posted Q1 earnings of $15.49 million, an increase from Q4 of 85.85%. Sales dropped to $323.08 million, a 30.79% decrease between quarters.

Benzinga

Applied Optoelectronics Earnings Perspective: Return On Invested Capital

Benzinga Pro data, Applied Optoelectronics (NASDAQ:AAOI) reported Q1 sales of $52.24 million. Earnings fell to a loss of $16.06 million, resulting in a 10.47% decrease from last quarter.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

CD&R, TPG Take Covetrus Private In $4B Deal

Clayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Capital will acquire animal-health technology and services company Covetrus Inc (NASDAQ:CVET) for $21.00 per share, representing an enterprise value of approximately $4 billion. CD&R and its affiliates currently beneficially own approximately 24% of the company's outstanding shares of common stock. The transaction…

Benzinga

Elevation Oncology Shares Gain On FDA Fast Track Designation For Seribantumab In Tumor-Agnostic Settings

Elevation Oncology, Inc. (NASDAQ: ELEV) received Fast Track designation from the Food and Drug Administration (FDA) for Seribantumab in tumor-agnostic settings for the treatment of advanced solid tumors that harbor NRG1 gene fusions.

Benzinga

Insiders Buy More Than $13M Of 3 Stocks

Although the Nasdaq Composite dropped around 270 points on Tuesday, there were a few notable insider trades.

Benzinga

MakeMyTrip Tops Q4 On Gradual Recovery Of Domestic Travel

Indian online travel company MakeMyTrip Limited (NASDAQ:MMYT) reported fourth-quarter FY22 revenue growth of 15.1% year-on-year (CC) to $88.6 million beating the consensus of $83.6 million. Revenue from the air ticketing business grew by 7.6% (CC) to $25.3 million, the hotels and packages business rose 22.0% (CC) to $45.1 million, bus ticketing business increased by 10.2%…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Tesla Battery Permit For Giga Texas Challenged By Environmentalists: Here's What They Want

A group of environmentalists has requested the city of Austin to withhold Tesla Inc’s (NASDAQ: TSLA) permits for building a battery cathode facility near the Colorado River, local news publication Austonia reported citing a letter fr

Benzinga

The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

DFFN: Data from Altitude Trial Expected in June 2022…

By David Bautz, PhD NASDAQ:DFFN READ THE FULL DFFN RESEARCH REPORT

Benzinga

EXCLUSIVE: Mike Tyson's Cannabis Brand Tyson 2.0 Appoints Alc-Bev Industry Veteran As Chief Marketing Officer

Mike Tyson’s cannabis brand, Tyson 2.0, appointed Jackie (Northacker) Guarini as chief marketing officer to lead the company’s marketing strategy.

Benzinga

Trades Are Mixed About Nvidia Ahead Of Earnings Release

Nvidia Corporation (NASDAQ: NVDA) is scheduled to report quarterly earnings on Wednesday after the closing bell. The Street expectations are for earnings of $1.30 per share on a slowdown in revenue growth.

Benzinga

Grab Loses Two Top Fintech Veterans Amid Its Business Restructuring: Reuters

Grab Holdings Limited (NASDAQ:GRAB) lost two top executives in its fintech business, adding to other senior departures as the Southeast Asian ride-hailing and delivery firm rejigs the critical unit at the loss-making group, Reuters reports. Chris Yeo, who headed Grab's payments and rewards business and has been with the company for nearly…

Benzinga

Morning Brief: Top Financial Stories Dominating on Wednesday, May 25

Reuters Ford To Pay $19.2M In Multi-State Settlement For False Advertising Claims

1 … 453 454 455 456

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.